Society
Events
Characterization of the metabolic profile and identification of potential therapeutic targets in advanced prostate cancer patients
Auditórium
11:30
Identificación de GRHL2 como biomarcador epigenético en la resistencia a terapias anti-EGFR en el cáncer de pulmón no microcítico
Auditórium
11:00 horas
LH administration as a potential strategy for ovarian protection and female preservation against highly gonadotoxic chemotherapy
Auditórium
10:00 horas.
Identificación de nuevos biomarcadores de trombosis venosa mediante técnicas ómicas
Auditórium
11:30
Characterization of the epigenetic modifications in human uterine leiomyomas and evaluation of their potential as therapeutic targets in vitro
Auditórium
12:00 h.
Metabolomic approach to physiological circumstances and pathological conditions in neonatology
Auditórium
10:00 horas.